• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

释放曲线的建模与比较:溶出方法的影响

Modeling and comparison of release profiles: Effect of the dissolution method.

作者信息

Cascone Sara

机构信息

Department of Industrial Engineering, University of Salerno, via Giovanni Paolo II 132, 84084 Fisciano, (SA), Italy.

出版信息

Eur J Pharm Sci. 2017 Aug 30;106:352-361. doi: 10.1016/j.ejps.2017.06.021. Epub 2017 Jun 14.

DOI:10.1016/j.ejps.2017.06.021
PMID:28627469
Abstract

During the last decades, the study of the in vitro dissolution of pharmaceuticals has been strongly encouraged by the FDA in order to determine its relationship with the in vivo bioavailability of a drug. In this work immediate and extended release formulations containing diclofenac, a BCS class II drug, were studied using different dissolution methods. The release profiles obtained in USP Apparatus II and USP Apparatus IV were evaluated and compared to determine the effect of the fluid dynamic conditions on the release. The influence of the mixing conditions (i.e. the paddle rotation speed in USP Apparatus II or the inlet flow rate in USP Apparatus IV) on the drug release were evaluated, finding that, for the extended release formulations, they do not affect significantly the release profile. An in vitro device simulating the peristaltic contractions of the stomach during the digestion was used to simulate fluid dynamics closer to the real physiology. The tablets were found to behave in a completely different way if tested in the artificial stomach. Both model-independent and model-dependent approaches were used to compare and fit the dissolution profiles, respectively. Fit factors were used as indicators of similarity of two dissolution profiles; model equations (such as zero-order, first-order, or Korsmeyer-Peppas equations) were used to fit the experimental data. With the identification of the best fitting model by the use of correlation factors and Akaike Information Criterion, the transport phenomena that determine the behavior of each formulation were identified.

摘要

在过去几十年中,美国食品药品监督管理局(FDA)大力推动了药物体外溶出度的研究,以确定其与药物体内生物利用度的关系。在这项工作中,使用不同的溶出方法对含有双氯芬酸(一种BCS II类药物)的速释和缓释制剂进行了研究。对在美国药典装置II和美国药典装置IV中获得的释放曲线进行了评估和比较,以确定流体动力学条件对释放的影响。评估了混合条件(即美国药典装置II中的桨叶转速或美国药典装置IV中的入口流速)对药物释放的影响,发现对于缓释制剂,它们对释放曲线没有显著影响。使用一种模拟消化过程中胃蠕动收缩的体外装置来模拟更接近真实生理状态的流体动力学。如果在人工胃中进行测试,发现这些片剂的行为方式完全不同。分别使用非模型依赖和模型依赖方法来比较和拟合溶出曲线。拟合因子用作两条溶出曲线相似性的指标;使用模型方程(如零级、一级或Korsmeyer-Peppas方程)来拟合实验数据。通过使用相关因子和赤池信息准则确定最佳拟合模型,确定了决定每种制剂行为的传输现象。

相似文献

1
Modeling and comparison of release profiles: Effect of the dissolution method.释放曲线的建模与比较:溶出方法的影响
Eur J Pharm Sci. 2017 Aug 30;106:352-361. doi: 10.1016/j.ejps.2017.06.021. Epub 2017 Jun 14.
2
In Vitro-In Vivo Predictive Dissolution-Permeation-Absorption Dynamics of Highly Permeable Drug Extended-Release Tablets via Drug Dissolution/Absorption Simulating System and pH Alteration.通过药物溶解/吸收模拟系统和 pH 值改变预测高渗透性药物缓释片的体外-体内预测溶解-渗透-吸收动力学。
AAPS PharmSciTech. 2018 May;19(4):1882-1893. doi: 10.1208/s12249-018-0996-1. Epub 2018 Apr 16.
3
Mechanistic Approach to Understanding the Influence of USP Apparatus I and II on Dissolution Kinetics of Tablets with Different Operating Release Mechanisms.理解美国药典装置I和II对具有不同释放机制的片剂溶出动力学影响的机制方法。
AAPS PharmSciTech. 2017 Feb;18(2):462-472. doi: 10.1208/s12249-016-0535-x. Epub 2016 Apr 22.
4
Influence of the physiological variability of fasted gastric pH and tablet retention time on the variability of in vitro dissolution and simulated plasma profiles.空腹胃液pH值和片剂滞留时间的生理变异性对体外溶出度和模拟血浆曲线变异性的影响。
Int J Pharm. 2014 Oct 1;473(1-2):552-9. doi: 10.1016/j.ijpharm.2014.07.031. Epub 2014 Jul 24.
5
Irregular absorption profiles observed from diclofenac extended release tablets can be predicted using a dissolution test apparatus that mimics in vivo physical stresses.使用模拟体内物理应力的溶出度试验装置,可以预测双氯芬酸缓释片的不规则吸收曲线。
Eur J Pharm Biopharm. 2008 Oct;70(2):421-8. doi: 10.1016/j.ejpb.2008.05.029. Epub 2008 Jun 7.
6
Pharmaceutical Product Lead Optimization for Better In vivo Bioequivalence Performance: A case study of Diclofenac Sodium Extended Release Matrix Tablets.优化药品以实现更好的体内生物等效性表现:双氯芬酸钠缓释骨架片的案例研究
Curr Drug Deliv. 2018;15(5):705-715. doi: 10.2174/1567201814666171120124551.
7
Report: in vitro dissolution studies of different brands of sustained release diclofenac sodium matrix tablet available in Bangladesh.报告:孟加拉国市场上不同品牌双氯芬酸钠缓释基质片的体外溶出度研究
Pak J Pharm Sci. 2008 Jan;21(1):70-7.
8
In vitro biorelevant models for evaluating modified release mesalamine products to forecast the effect of formulation and meal intake on drug release.用于评估美沙拉嗪缓释产品以预测制剂和进餐对药物释放影响的体外生物相关模型。
Eur J Pharm Biopharm. 2015 Nov;97(Pt A):39-50. doi: 10.1016/j.ejpb.2015.09.002. Epub 2015 Sep 21.
9
Effect of Coadministered Water on the In Vivo Performance of Oral Formulations Containing N-Acetylcysteine: An In Vitro Approach Using the Dynamic Open Flow-Through Test Apparatus.共处理水对含 N-乙酰半胱氨酸口服制剂体内性能的影响:采用动态开放流动通过测试装置的体外方法。
Mol Pharm. 2017 Dec 4;14(12):4272-4280. doi: 10.1021/acs.molpharmaceut.7b00763. Epub 2017 Nov 3.
10
Influence of dissolution medium agitation on release profiles of sustained-release tablets.溶出介质搅拌对缓释片释放曲线的影响
Drug Dev Ind Pharm. 2001 Sep;27(8):811-7. doi: 10.1081/ddc-100107244.

引用本文的文献

1
High-Expansion Natural Composite Films for Controlled Delivery of Hydroxycitric Acid in Obesity Therapy.用于肥胖治疗中羟基柠檬酸控释的高膨胀天然复合膜
Polymers (Basel). 2025 Jun 18;17(12):1697. doi: 10.3390/polym17121697.
2
Influence of Polymer Film Thickness on Drug Release from Fluidized Bed Coated Pellets and Intended Process and Product Control.聚合物薄膜厚度对流化床包衣微丸药物释放的影响及预期的工艺和产品控制
Pharmaceutics. 2024 Oct 8;16(10):1307. doi: 10.3390/pharmaceutics16101307.
3
A pH-Responsive Ti-Based Local Drug Delivery System for Osteosarcoma Therapy.
一种用于骨肉瘤治疗的pH响应型钛基局部给药系统。
J Funct Biomater. 2024 Oct 21;15(10):312. doi: 10.3390/jfb15100312.
4
Rapid Synthesis and Evaluation of Resveratrol-Piperazine Cocrystals by Ultrasound and Microwave Methods.通过超声和微波方法快速合成与评估白藜芦醇-哌嗪共晶体
Pharm Res. 2024 Sep;41(9):1843-1853. doi: 10.1007/s11095-024-03758-3. Epub 2024 Aug 7.
5
Comparative Fitting of Mathematical Models to Carvedilol Release Profiles Obtained from Hypromellose Matrix Tablets.数学模型对从羟丙甲纤维素基质片剂获得的卡维地洛释放曲线的比较拟合
Pharmaceutics. 2024 Apr 4;16(4):498. doi: 10.3390/pharmaceutics16040498.
6
Development of a Discriminative Dissolution Method, Using In-Silico Tool for Hydrochlorothiazide and Valsartan Tablets.使用计算机模拟工具开发氢氯噻嗪和缬沙坦片的鉴别溶出方法。
Pharmaceutics. 2023 Jun 14;15(6):1735. doi: 10.3390/pharmaceutics15061735.
7
Semi-mechanistic reduced order model of pharmaceutical tablet dissolution for enabling Industry 4.0 manufacturing systems.用于实现工业 4.0 制造系统的药物片剂溶出的半机械简化模型。
Int J Pharm. 2023 Jan 25;631:122502. doi: 10.1016/j.ijpharm.2022.122502. Epub 2022 Dec 16.
8
Modeling of In Vitro Dissolution Profiles of Carvedilol Immediate-Release Tablets in Different Dissolution Media.卡维地洛普通片在不同溶出介质中的体外溶出曲线模拟。
AAPS PharmSciTech. 2022 Jul 26;23(6):201. doi: 10.1208/s12249-022-02355-0.
9
Formulation and characterization of eprosartan mesylate and β-cyclodextrin inclusion complex prepared by microwave technology.采用微波技术制备甲磺酸依普罗沙坦和β-环糊精包合物的配方及特性研究。
Drug Deliv. 2022 Dec;29(1):1512-1522. doi: 10.1080/10717544.2022.2072540.
10
Sintered porous Ti6Al4V scaffolds incorporated with recombinant human bone morphogenetic protein-2 microspheres and thermosensitive hydrogels can enhance bone regeneration.掺入重组人骨形态发生蛋白-2微球和热敏水凝胶的烧结多孔Ti6Al4V支架可促进骨再生。
RSC Adv. 2019 Jan 11;9(3):1541-1550. doi: 10.1039/c8ra10200g. eCollection 2019 Jan 9.